Rapid release tablet formulation of micronized danazol powder produced by spray-freezing into liquid (SFL)

Jun Hu; Keith P. Johnston; Robert O. Williams

doi:10.1016/s1773-2247(04)50052-7

Rapid release tablet formulation of micronized danazol powder produced by spray-freezing into liquid (SFL)

Jun Hu, Keith P. Johnston, Robert O. Williams

In: Journal of Drug Delivery Science and Technology · 2004 · vol. 14(4) , pp. 305–311 · doi:10.1016/s1773-2247(04)50052-7 · W1998299820

article OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Spray-freezing into liquid (SFL) successfully produced micronized danazol powder for a rapidly dissolving tablet formulation, enhancing drug dissolution.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (37)

Bioavailability of danazol-hydroxypropyl-β-cylodextrin complex by different routes of administration via openalex
Improvement of Dissolution Rates of Poorly Water Soluble APIs Using Novel Spray Freezing into Liquid Technology via openalex
In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs via openalex
Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs via openalex
Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules via openalex
Stable Amorphous Danazol Nanostructured Powders with Rapid Dissolution Rates Produced by Spray Freezing into Liquid via openalex
doi:10.1016/s1461-5347(99)00237-0 via openalex
doi:10.1002/jps.1094 via openalex
doi:10.1016/s0169-409x(02)00070-4 via openalex
doi:10.1016/s0168-3659(98)00108-4 via openalex
doi:10.1016/0040-6031(94)01949-h via openalex
doi:10.1021/ja01269a023 via openalex
W2808418025 via openalex
W6644603084 via openalex
W6663701257 via openalex
doi:10.1081/ddc-100108363 via openalex
doi:10.1016/s0921-5093(03)00059-5 via openalex
doi:10.1016/s0378-5173(02)00375-7 via openalex
doi:10.1016/s0939-6411(02)00063-2 via openalex
doi:10.1023/a:1016292416526 via openalex
doi:10.1016/s0928-0987(03)00203-3 via openalex
doi:10.1016/s0376-7388(00)00422-1 via openalex
doi:10.1016/s0378-5173(03)00062-0 via openalex
doi:10.1016/s0378-5173(01)00993-0 via openalex
doi:10.1023/a:1022628826404 via openalex
doi:10.1016/s0378-5173(01)00767-0 via openalex
doi:10.18356/9789210059091c023 via openalex
doi:10.1016/s0928-0987(02)00251-8 via openalex
doi:10.1016/s0022-0248(99)00819-2 via openalex
doi:10.1016/s0378-5173(02)00154-0 via openalex
doi:10.1016/s0378-5173(98)00248-8 via openalex
doi:10.1016/s0939-6411(02)00050-4 via openalex
doi:10.1016/s0378-5173(01)00880-8 via openalex
doi:10.1023/a:1016212804288 via openalex
doi:10.1016/s0939-6411(03)00037-7 via openalex
doi:10.1016/s0260-8774(99)00039-4 via openalex
doi:10.3109/03639049609041979 via openalex

Source provenance

openalex: last seen: 2026-05-10T11:20:05.950390+00:00

License: CC0 · commercial use OK

[1] Bioavailability of danazol-hydroxypropyl-β-cylodextrin complex by different routes of administration via openalex

[2] Improvement of Dissolution Rates of Poorly Water Soluble APIs Using Novel Spray Freezing into Liquid Technology via openalex

[3] In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs via openalex

[4] Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs via openalex

[5] Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules via openalex

[6] Stable Amorphous Danazol Nanostructured Powders with Rapid Dissolution Rates Produced by Spray Freezing into Liquid via openalex

[7] doi:10.1016/s1461-5347(99)00237-0 via openalex

[8] doi:10.1002/jps.1094 via openalex

[9] doi:10.1016/s0169-409x(02)00070-4 via openalex

[10] doi:10.1016/s0168-3659(98)00108-4 via openalex

[11] doi:10.1016/0040-6031(94)01949-h via openalex

[12] doi:10.1021/ja01269a023 via openalex

[13] W2808418025 via openalex

[14] W6644603084 via openalex

[15] W6663701257 via openalex

[16] doi:10.1081/ddc-100108363 via openalex

[17] doi:10.1016/s0921-5093(03)00059-5 via openalex

[18] doi:10.1016/s0378-5173(02)00375-7 via openalex

[19] doi:10.1016/s0939-6411(02)00063-2 via openalex

[20] doi:10.1023/a:1016292416526 via openalex

[21] doi:10.1016/s0928-0987(03)00203-3 via openalex

[22] doi:10.1016/s0376-7388(00)00422-1 via openalex

[23] doi:10.1016/s0378-5173(03)00062-0 via openalex

[24] doi:10.1016/s0378-5173(01)00993-0 via openalex

[25] doi:10.1023/a:1022628826404 via openalex

[26] doi:10.1016/s0378-5173(01)00767-0 via openalex

[27] doi:10.18356/9789210059091c023 via openalex

[28] doi:10.1016/s0928-0987(02)00251-8 via openalex

[29] doi:10.1016/s0022-0248(99)00819-2 via openalex

[30] doi:10.1016/s0378-5173(02)00154-0 via openalex

[31] doi:10.1016/s0378-5173(98)00248-8 via openalex

[32] doi:10.1016/s0939-6411(02)00050-4 via openalex

[33] doi:10.1016/s0378-5173(01)00880-8 via openalex

[34] doi:10.1023/a:1016212804288 via openalex

[35] doi:10.1016/s0939-6411(03)00037-7 via openalex

[36] doi:10.1016/s0260-8774(99)00039-4 via openalex

[37] doi:10.3109/03639049609041979 via openalex